The polypharmaceutical nature of modern health care, with an estimated 29% of Americans taking five or more medications on a regular basis, requires oral health professionals to have a thorough understanding of possible drug interactions.
The United States Food and Drug Administration (FDA) released a template for companies to use in obtaining emergency use authorization for rapid COVID-19 testing that can be performed in homes, offices, schools, and other non-medical…
A system of classification for periodontal and peri-implant diseases allows clinicians to properly diagnose and treat individuals with periodontal and peri-implant conditions.
With the COVID-19 pandemic showing no signs of abating in the United States and while pharmaceutical companies hustle to develop a safe and effective vaccine, considering how such a vaccine will be distributed is prudent. The US Centers for…
Xerostomia, or perceived dry mouth, has a broad range of prevalence, ranging from 5.5% to 65%, while also considered under-reported by patients and under-recognized by practitioners. As such, it is important for oral health professionals to…
A relative of the novel coronavirus, RaTG13, has been present in bats for the past 40 to 70 years, according to new research published in Nature Biology. The Scottish study suggests that SARS-CoV-2 has likely been poised to crossover to…
Anthony Fauci, MD, head of the National Institute of Allergy and Infectious Diseases, recently suggested that wearing eye goggles or eye shields by everyday citizens could reduce community spread of COVID-19. He noted that the eye has…
After data demonstrated Johnson and Johnson’s (J&J) one-dose vaccine offered significant protection against COVID-19 in monkeys, the pharmaceutical giant started human trials on July 30. The initial trial includes 1,000 adults in both…